Table 3. Comparison of maternal dengue seroprevalence, maternal and cord sera dengue antibody titers in various articles.
Methods | Seroprevalence (%) | Maternal GMTs | Cord GMTs | p* | |
---|---|---|---|---|---|
Pengsaa K, et al[17] | PRNT50 | 95.2 | - | 53.5–258.2 a | n/a |
Watanaveeradej V, et al[25] | HAI | 96.8 | - | - | n/a |
IgG | - | 62.7±85.8 b | 99.8±448 b | n.d. | |
Perret C, et al[26] | HAI | 94.7 | 41.3–104 a | 50.8–128.2 a | <0.01 d |
Pengsaa K, et al[18] | PRNT50 | 97.3 | 82.1–731 a | 78.6–692 a | n.d. |
Chau TNB, et al[28] | PRNT50, | 98 | 26–53 a 913 (582–1,297) c | 30–80 a 1,025 (600–1,429) c | <0.001 e |
IgG | 913 (582–1,297) c | 1,025 (600–1,429) c | 0.002 | ||
Argolo AF, et al[27] | IgG | 53.9 | - | - | n/a |
This study | PRNT50 | 97.2 | 90.3–246 a | 120.7–308.1 a | <0.001 |
* p-values are based on paired sample t-test
a range
b mean±SD
c mg/dL, GMT (range)
d p-value 0.002 for DEN-1, 0.003 for DEN-3 and <0.001 for DEN-2 and DEN-4
e p-value <0.001 for DEN-2 and DEN-3 only, p-value for DEN-1 and DEN-4 ≥ 0.5
n/a = not applicable, n.d. = no data available